Valeant Pharmaceuticals International Inc (VRX.TO), (VRX.N) said on Monday it would sell its Obagi Medical Products business for $190 million in cash, as part of the Canadian drugmaker’s efforts to cut down its...
Singh brothers seek urgent funds to repay Religare debt
RHC Holding Pvt. Ltd, a company through which brothers Malvinder and Shivinder Singh own shares in Fortis Healthcare and Religare Group companies, has approached lenders for urgent funds to meet repayment obligations of...
Sanofi to buy vaccines biotech group Protein Sciences
French drugmaker and healthcare group Sanofi is to buy privately-held U.S vaccines biotech company Protein Sciences for an initial amount of $650 million, as Sanofi steps up its acquisition program after recently...
GSK Pharma to invest Rs 1,000 crore in Karnataka plant
Global healthcare company GlaxoSmithKline PharmaceuticalsBSE 0.30 % Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas...
Celgene to buy BeiGene stake, to develop tumor cancer treatment
Biopharmaceutical company Celgene Corp will buy a stake in BeiGene Ltd and help develop and commercialize BeiGene’s investigational treatment for tumor cancers, the companies said on Wednesday. Celgene will...
Sun Pharmaceutical signs agreement with Samsung BioLogics for psoriasis drug
Sun PharmaceuticalBSE 0.49 % Industries, India’s largest drug maker, signed a long-term agreement with South Korea’s Samsung BioLogics for the manufacture of an experimental medicine to treat psoriasis. The novel drug...
Samara Capital likely to buy Novartis brands
Months after sealing a deal with Ahmedabad-based Torrent Pharma for the sale of two of its leading women’s healthcare brands, Swiss pharmaceutical major NovartisBSE 0.81 % AG is now in advanced stages of selling...
Walgreens scraps Rite Aid merger, will instead buy half its stores
Drugstore chain Walgreens Boots Alliance Inc scrapped its deal to buy Rite Aid Corp after failing to win antitrust approval, but said it would instead buy nearly half of the smaller rival’s U.S. stores for $5.18...
Hedge fund Paulson & Co discloses 6.3 percent stake in Valeant
New York-based hedge fund Paulson & Co on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N). The disclosure comes a week after billionaire...
Stada buyout falls short of shareholder acceptance target
Private equity groups Bain Capital and Cinven failed to win the required shareholder acceptances to take over German generic drugmaker Stada (STAGn.DE), the companies said late on Monday. Investors representing 65.52...
Delhi HC allows Singh brothers to sell Fortis stake with a rider
The Delhi high court on Wednesday cleared the way for former Ranbaxy promoters Malvinder and Shivinder Singh to potentially sell a stake in Fortis Healthcare Ltd on the condition that the disclosed value of their...
Daiichi moves court to stop Malvinder and Shivinder Singh from selling Fortis stake
As negotiations between former Ranbaxy promoters Malvinder and Shivinder Singh and Malaysia-based healthcare group IHH Healthcare Bhd reach final stages for a stake sale in Fortis Healthcare, Japanese drugmaker Daiichi...
